New drug aims to ease stuttering without harsh side effects
NCT ID NCT05583955
Summary
This study tested an experimental drug called NOE-105 to see if it could improve speech fluency in adult men with persistent stuttering that began in childhood. For 10 weeks, 75 participants received either the drug or a placebo to compare effectiveness and safety. The main goal was to see if the drug could reduce stuttering severity and improve daily functioning compared to a dummy pill.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHILDHOOD-ONSET FLUENCY DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Noema Investigator site
Bellflower, California, 90706, United States
-
Noema Investigator site
Jacksonville, Florida, 32256, United States
-
Noema Investigator site
Orlando, Florida, 32801, United States
-
Noema Investigator site
Overland Park, Kansas, 66210, United States
-
Noema Investigator site
Berlin, New Jersey, 08009, United States
-
Noema Investigator site
Memphis, Tennessee, 38119, United States
-
Noema Investigator site
Brookvale, New South Wales, 2100, Australia
-
Noema Investigator site
Miranda, New South Wales, 2228, Australia
-
Noema Investigator site
Sydney, New South Wales, 2109, Australia
Conditions
Explore the condition pages connected to this study.